Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Controlled Release

• Publication date

  2016-08-10

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1016/j.jconrel.2016.05.052PMID 27235980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized controlled trial to evaluate performance of pigs raised in antibiotic-free or conventional production systems following challenge with porcine reproductive and respiratory syndrome virus

  2018cited by this paper
• Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease

  2016cited by this paper
• Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.

  2016cited by this paper
• Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound.

  2016cited by this paper
• GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease

  2015cited by this paper
• Focused ultrasound-induced blood–brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study

  2015cited by this paper
• Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery.

  2015cited by this paper
• Alzheimer disease in a mouse model: MR imaging-guided focused ultrasound targeted to the hippocampus opens the blood-brain barrier and improves pathologic abnormalities and behavior.

  2014cited by this paper
• The Effects of Aging on Substantia Nigra Dopamine Neurons

  2014cited by this paper
• Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy.

  2014cited by this paper
• Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.

  2014cited by this paper
• Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers.

  2013cited by this paper
• Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy.

  2013cited by this paper
• Neuronavigation-Guided Focused Ultrasound-Induced Blood-Brain Barrier Opening: A Preliminary Study in Swine

  2013cited by this paper
• Parkinson's disease: gene therapies.

  2012cited by this paper
• Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.

  2011cited by this paper
• Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain

  2010cited by this paper
• Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.

  2010cited by this paper
• Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery.

  2010cited by this paper
• Ultrasound exposure of lipoplex loaded microbubbles facilitates direct cytoplasmic entry of the lipoplexes.

  2009cited by this paper
• Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.

  2009cited by this paper
• Activity of Neurochemically Heterogeneous Dopaminergic Neurons in the Substantia Nigra during Spontaneous and Driven Changes in Brain State

  2009cited by this paper
• Premotor Parkinson's disease: Clinical features and detection strategies

  2009cited by this paper
• Premotor Parkinson's disease: Clinical features, detection, and prospects for treatment

  2008cited by this paper
• The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats.

  2008cited by this paper
• Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound.

  2007cited by this paper
• Protocol for the MPTP mouse model of Parkinson's disease

  2007cited by this paper
• GDNF as a candidate striatal target-derived neurotrophic factor for the development of substantia nigra dopamine neurons.

  2006cited by this paper
• Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2.

  2006cited by this paper
• Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications

  2005cited by this paper
• Genetics of Parkinson disease

  2004cited by this paper
• Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

  2003cited by this paper
• Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

  2003cited by this paper
• Development of gene drug delivery systems based on pharmacokinetic studies.

  2001cited by this paper
• Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits.

  2001cited by this paper
• Sustained delivery of GDNF: towards a treatment for Parkinson's disease.

  2001cited by this paper
• Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects.

  2000cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• Nigral and extranigral pathology in Parkinson's disease.

  1995cited by this paper
• Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: A review

  1991cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease.

  2026cites this paper
• Transcranial focused ultrasound in the human brain.

  2026cites this paper
• Sugar transporter SLC45 gene family members: roles in malignant tumors and research progress

  2026cites this paper
• Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain

  2026cites this paper
• MicroRNAs and synaptic dysfunction in Parkinson’s disease

  2025cites this paper
• The Intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders.

  2025cites this paper
• Transcranial Focused Ultrasound: A Transformative Tool for Intracranial Ablation, Drug Delivery, and Neuromodulation

  2025cites this paper
• Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems.

  2025cites this paper
• Data-driven feedback augments ultrasound nanotheranostics in brain tumors

  2025cites this paper
• The Application of Ultrasound-Induced Blood-Brain Barrier Opening in Neurology and Immunology.

  2025cites this paper
• Enhanced blood–brain barrier opening induced by focused ultrasound combined with microbubble clusters trapped by an acoustic vortex tweezer

  2025cites this paper
• Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases

  2025cites this paper
• Imaging strategies to assess efficacy and safety of ultrasound-induced blood-brain barrier opening

  2025cites this paper
• Brain Targeting Nanomedicines: Pitfalls and Promise

  2024influential citation
• Neuroprotection effects of kynurenic acid-loaded micelles for the Parkinson’s disease models

  2024cites this paper
• Noninvasive focused ultrasound-mediated delivery of rAAV9-EGFP vectors for neuronal targeting in rats

  2024cites this paper
• Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases.

  2024cites this paper
• Focused ultrasound on the substantia nigra enables safe neurotensin-polyplex nanoparticle-mediated gene delivery to dopaminergic neurons intranasally and by blood circulation

  2024cites this paper
• Translating ultrasound-mediated drug delivery technologies for CNS applications.

  2024cites this paper
• 1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?

  2024cites this paper
• Lipid-based nanoparticles for drug delivery in Parkinson’s disease

  2024cites this paper
• Very Low‐Intensity Ultrasound Facilitates Glymphatic Influx and Clearance via Modulation of the TRPV4‐AQP4 Pathway

  2024cites this paper
• Precision medicine focus on the central nervous system: Non-invasive therapeutic agent delivery with focused ultrasound and microbubbles.

  2024cites this paper
• Ultrasound Contrast Agents: Current Role in Adults and Children for Various Indications.

  2024cites this paper
• Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety

  2024cites this paper
• Brain Nucleic Acid Delivery and Genome Editing via Focused Ultrasound-Mediated Blood-Brain Barrier Opening and Long-Circulating Nanoparticles.

  2024cites this paper
• Focused Ultrasound for Neurodegenerative Diseases.

  2024cites this paper
• Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma

  2024cites this paper
• Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets

  2024cites this paper
• Advances in microbubble-assisted ultrasound-guided gene therapy: Mechanisms and applications

  2024cites this paper
• Gene therapy for CNS disorders: modalities, delivery and translational challenges

  2024cites this paper
• Ultrasound Tissue Engineering Technology for Regulating Immune Microenvironment

  2024cites this paper
• Focused ultrasound therapy: Back to the future.

  2024cites this paper
• Enhanced macromolecular substance extravasation through the blood-brain barrier via acoustic bubble-cell interactions

  2024cites this paper
• Focused ultrasound gene delivery for the treatment of neurological disorders.

  2024cites this paper
• Shedding light on ultrasound in action: Optical and optoacoustic monitoring of ultrasound brain interventions

  2024cites this paper
• Micro/nanoparticle-enabled ultrasound therapy of brain diseases

  2024cites this paper
• Development of bioactive and ultrasound-responsive microdroplets for preventing ovariectomy (OVX)-induced osteoporosis.

  2023cites this paper
• Chaihu and Longgu Muli Decoction Demonstrate Neuroprotective Effects in the Rat Model of Parkinson's Disease with Depression by Regulating the AMPK/mTOR Signaling Pathway

  2023cites this paper
• Small volume blood-brain barrier opening in macaques with a 1 MHz ultrasound phased array.

  2023cites this paper
• Biomaterial‐Based Gene Delivery to Central Nervous System Cells for the Treatment of Spinal Cord Injury

  2023cites this paper
• Low intensity focused ultrasound: a new prospect for the treatment of Parkinson’s disease

  2023cites this paper
• Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models

  2023cites this paper
• Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma

  2023cites this paper
• Strategic nanocarriers to control neurodegenerative disorders: concept, challenges, and future perspective.

  2023cites this paper
• Low-Intensity Focused Ultrasound Neuromodulation for Stroke Recovery: A Novel Deep Brain Stimulation Approach for Neurorehabilitation?

  2023cites this paper
• Design of a 1-MHz Therapeutic Ultrasound Array for Small Volume Blood-Brain Barrier Opening at Cortical Targets in Macaques

  2023cites this paper
• Small volume blood-brain barrier opening in macaques with a 1 MHz ultrasound phased array

  2023cites this paper
• Preclinical Research on Focused Ultrasound-Mediated Blood–Brain Barrier Opening for Neurological Disorders: A Review

  2023cites this paper
• Intercellular Calcium Waves and Permeability Change Induced by Vertically Deployed Surface Acoustic Waves in a Human Cerebral Microvascular Endothelial Cell Line (hCMEC/D3) Monolayer.

  2023cites this paper
• AHNAK-modified microbubbles for the intracranial delivery of triptolide: In-vitro and in-vivo investigations.

  2022cites this paper
• Recent Trend of Ultrasound-Mediated Nanoparticle Delivery for Brain Imaging and Treatment.

  2022cites this paper
• Focused Ultrasound-Induced Blood–Brain Barrier Opening Enhanced α-Synuclein Expression in Mice for Modeling Parkinson’s Disease

  2022cites this paper
• “Focused Ultrasound-mediated Drug Delivery in Humans – a Path Towards Translation in Neurodegenerative Diseases”

  2022cites this paper
• Gene and oligonucleotide delivery via micro- and nanobubbles by ultrasound exposure.

  2022cites this paper
• Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound?

  2022cites this paper
• Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy

  2022cites this paper
• Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials

  2022cites this paper
• Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies

  2022cites this paper
• Focused Ultrasound Promotes the Delivery of Gastrodin and Enhances the Protective Effect on Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

  2022cites this paper
• Non-invasive optogenetics with ultrasound-mediated gene delivery and red-light excitation

  2022cites this paper
• A review on the current progress of layered double hydroxide application in biomedical sectors

  2022cites this paper
• Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases

  2022cites this paper
• Passive Cavitation Enhancement Mapping via an Ultrasound Dual-Mode phased array to monitor blood-brain barrier opening

  2022cites this paper
• Ultrasound combined with glial cell line-derived neurotrophic factor-loaded microbubbles for the targeted treatment of drug addiction

  2022influential citation
• Ultrasound-mediated blood-brain barrier opening: an effective drug delivery system for theranostics of brain diseases.

  2022cites this paper
• Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions.

  2022cites this paper
• Applications of Focused Ultrasound-Mediated Blood-Brain Barrier Opening.

  2022cites this paper
• Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier

  2022cites this paper
• Surgical Management of Synucleinopathies

  2022cites this paper
• Methylene Blue Delivery Mediated by Focused Ultrasound-Induced Blood–Brain Barrier Disruption Reduces Neural Damage and Amyloid-Beta Plaques by AQP-4 Upregulation

  2022cites this paper
• A single low-energy shockwave pulse opens blood-cerebrospinal fluid barriers and facilitates gastrodin delivery to alleviate epilepsy

  2021cites this paper
• Focused Ultrasound Combined with Microbubbles in Central Nervous System Applications

  2021cites this paper
• Ultrasound-Responsive Systems as Components for Smart Materials

  2021cites this paper
• Ternary Complexes of pDNA, Neuron-Binding Peptide, and PEGylated Polyethyleneimine for Brain Delivery with Nano-Bubbles and Ultrasound

  2021cites this paper
• Nanomaterials as novel agents for amelioration of Parkinson’s disease

  2021cites this paper
• Ultrasonic technologies in imaging and drug delivery

  2021cites this paper
• Development and application of ultrasound contrast agents in biomedicine.

  2021cites this paper
• The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication

  2021cites this paper
• Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain

  2021cites this paper
• Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery Systems

  2021cites this paper
• Characterization of ultrasound-mediated delivery of trastuzumab to normal and pathologic spinal cord tissue

  2021cites this paper
• Nanotechnology in neurosurgery: a systematic review

  2021cites this paper
• Focused Ultrasound Mediated Opening of the Blood-Brain Barrier for Neurodegenerative Diseases

  2021cites this paper
• Gene therapy strategies for rare monogenic disorders with nuclear or mitochondrial gene mutations.

  2021cites this paper
• Recent Strategies for Targeted Brain Drug Delivery.

  2020cites this paper
• A Single High-Intensity Shock Wave Pulse With Microbubbles Opens the Blood-Brain Barrier in Rats

  2020influential citation
• Transcriptomic Profiling of Circular RNA in Different Brain Regions of Parkinson’s Disease in a Mouse Model

  2020cites this paper
• Quantitative analysis of the focused ultrasound-induced blood-brain barrier opening with applications in neurodegenerative disorders

  2020cites this paper
• Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment.

  2020cites this paper
• Cell and Tissue Instructive Materials for Central Nervous System Repair

  2020cites this paper
• Ultrasound-mediated diagnostic imaging and advanced treatment with multifunctional micro/nanobubbles.

  2020cites this paper
• Liposomes: Novel Drug Delivery Approach for Targeting Parkinson's Disease.

  2020cites this paper
• Neuroprotection in animal models of Parkinson's disease: exploring exercise, sound, and light

  2020cites this paper
• Nanoparticles for drug delivery in Parkinson’s disease

  2020cites this paper
• Focused Ultrasound-Mediated Blood-Brain Barrier Disruption for Enhanced Drug Delivery to Brain Tumors

  2020cites this paper
• Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB

  2020cites this paper
• Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.

  2020cites this paper
• Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases

  2020cites this paper
• Recent Advances on Ultrasound Contrast Agents for Blood-Brain Barrier Opening with Focused Ultrasound

  2020cites this paper